Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and phenylalanine arginine beta-naphthylamide

levofloxacin has been researched along with phenylalanine arginine beta-naphthylamide in 7 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(phenylalanine arginine beta-naphthylamide)		Trials
(phenylalanine arginine beta-naphthylamide)		Recent Studies (post-2010) (phenylalanine arginine beta-naphthylamide)
4,3465812,20995051

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamberland, S; Dudley, MN; Filonova, L; Flamme, EM; Griffith, D; Ishida, Y; Lee, VJ; Léger, R; Lomovskaya, O; Madsen, D; Nakayama, K; Ohta, T; Renau, TE; Wang, M; Watkins, WJ; Yen, R1
Deering, RW; Mincer, TJ; Poulson-Ellestad, KL; Rowley, DC; Whalen, KE1
Blais, J; Chamberland, S; Cho, D; Fronko, R; Galazzo, J; Hecker, S; Hoshino, K; Ishida, H; Lee, A; Lee, M; Lee, VJ; Leger, R; Lomovskaya, O; Renau, T; Warren, MS; Watkins, W1
Coban, AY; Durupinar, B; Ekinci, B1
Izard, D; Mullié, C; Sonnet, P1
Bowlin, TL; D'Souza, S; Houseweart, C; Kim, HS; Kwasny, SM; Nguyen, ST; Nikaido, H; Opperman, TJ; Peet, NP; Walker, GC1
Ahn, J; Jo, A1

Other Studies

7 other study(ies) available for levofloxacin and phenylalanine arginine beta-naphthylamide

ArticleYear
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Aminobutyrates; Aminoquinolines; Animals; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Drug Synergism; Lethal Dose 50; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Mice; Ofloxacin; Ornithine; Pseudomonas aeruginosa; Structure-Activity Relationship

2003
Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.
    Journal of natural products, 2015, Mar-27, Volume: 78, Issue:3

    Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple; Fluorescent Dyes; Gram-Negative Bacteria; Membrane Transport Proteins; Metabolomics; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudoalteromonas; Pseudomonas aeruginosa; Pyrroles

2015
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Carrier Proteins; Cephalosporins; Dipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Levofloxacin; Magnetic Resonance Spectroscopy; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Pseudomonas aeruginosa

2001
A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates.
    Chemotherapy, 2004, Volume: 50, Issue:1

    Topics: Bacterial Outer Membrane Proteins; Ciprofloxacin; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa

2004
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Levofloxacin; Membrane Transport Modulators; Microbial Sensitivity Tests; Piperacillin; Pyrans; Pyridines

2014
Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.
    BMC microbiology, 2016, 07-29, Volume: 16, Issue:1

    Topics: Adhesins, Bacterial; Bacterial Adhesion; Bacterial Proteins; beta-Lactamases; Biofilms; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Coagulase; Dipeptides; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genotype; Imipenem; Levofloxacin; Membrane Transport Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Phenotype; Polymerase Chain Reaction; Staphylococcus aureus; Streptomycin

2016